Citation Impact
Citing Papers
Recent Molecular Genetic Explorations of Caenorhabditis elegans MicroRNAs
2018 StandoutNobel
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
2010
Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice
2011
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1
2016 Standout
Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
2014 Standout
Transcriptional Regulation by Nrf2
2017 Standout
Human disease locus discovery and mapping to molecular pathways through phylogenetic profiling
2013 StandoutNobel
DNA-Damage-Induced Nuclear Export of Precursor MicroRNAs Is Regulated by the ATM-AKT Pathway
2013
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis
2016
Intracellular Delivery System for Antibody–Peptide Drug Conjugates
2015 StandoutNobel
The p53 Pathway Encounters the MicroRNA World
2009
The DBHS proteins SFPQ, NONO and PSPC1: a multipurpose molecular scaffold
2016
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Regulation of microRNA function in animals
2018 Standout
Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD)
2006
Pancreatic cancer
2004 Standout
Targeting hypoxia in cancer therapy
2011 Standout
A microRNA family exerts maternal control on sex determination in C. elegans
2017 StandoutNobel
The p53/miR-34 axis in development and disease
2014
Induction of AKR1C2 by Phase II Inducers: Identification of a Distal Consensus Antioxidant Response Element Regulated by NRF2
2006
Curcumin exerts its antitumor effects in a context dependent fashion
2018
Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles
2011
Regulation of microRNA biogenesis
2014 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
A glitch in the matrix: organ-specific matrisomes in metastatic niches
2021
The multidimensional mechanisms of long noncoding RNA function
2017 Standout
Trial Watch: Monoclonal antibodies in cancer therapy
2012
Cancer Cell Metabolism: Warburg and Beyond
2008 Standout
PUMA, a potent killer with or without p53
2008
The miR-34 family in cancer and apoptosis
2009
The changing landscape of atherosclerosis
2021 StandoutNature
microRNA-34a/c function as tumor suppressors in Hep-2 laryngeal carcinoma cells and may reduce GALNT7 expression
2014
The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: Implications for leukemogenesis
2009
Pre-metastatic Niche Formation in Different Organs Induced by Tumor Extracellular Vesicles
2021
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Non-viral vectors for gene-based therapy
2014 Standout
Noncoding RNAs and pancreatic cancer
2016
Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis
2014
piRNAs and piRNA-Dependent siRNAs Protect Conserved and Essential C. elegans Genes from Misrouting into the RNAi Pathway
2015 StandoutNobel
Targeting apoptosis in cancer therapy
2020 Standout
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
2011
Human Cytosolic 3α-Hydroxysteroid Dehydrogenases of the Aldo-keto Reductase Superfamily Display Significant 3β-Hydroxysteroid Dehydrogenase Activity
2004
Androgen action and metabolism in prostate cancer
2012
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Autophagy modulation as a potential therapeutic target for diverse diseases
2012 Standout
Oxidative Stress in Cancer
2020 Standout
Activation of apoptosis signalling pathways by reactive oxygen species
2016 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Diagnosis of hyperandrogenism: Biochemical criteria
2006
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
2014 Standout
Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas
2011
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Long noncoding RNAs as Organizers of Nuclear Architecture
2016
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Epithelial Mesenchymal Transition and Pancreatic Tumor Initiating CD44+/EpCAM+ Cells Are Inhibited by γ-Secretase Inhibitor IX
2012
The complexities of microRNA regulation: mirandering around the rules
2009
Polycystic ovary syndrome
2016 Standout
miR-34 – a microRNA replacement therapy is headed to the clinic
2012
Quantitative Super-Resolution Microscopy of the Mammalian Glycocalyx
2019 StandoutNobel
Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9
2013
Pervasive and Cooperative Deadenylation of 3′UTRs by Embryonic MicroRNA Families
2010
Extracellular vesicles: biology and emerging therapeutic opportunities
2013 Standout
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
miR-34 activity is modulated through 5′-end phosphorylation in response to DNA damage
2016
Pancreatic cancer
2011 Standout
Microvesicles Derived from Adult Human Bone Marrow and Tissue Specific Mesenchymal Stem Cells Shuttle Selected Pattern of miRNAs
2010
The role of MicroRNAs in human cancer
2016 Standout
Supramolecular biomaterials
2015 Standout
Aldo-Keto Reductases and Bioactivation/Detoxication
2006
The role of estrogens in prostate carcinogenesis: a rationale for chemoprevention.
2005
Notch Signaling Pathway in Pancreatic Cancer Progression
2013
Resveratrol as an anti-cancer agent: A review
2016
Pancreatic Cancer Stem Cells
2008
Personalized Medicine: Progress and Promise
2011
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Splicing regulation by long noncoding RNAs
2018
An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men with Castrate-Resistant Prostate Cancer
2009
Small-Molecule Bcl-2 Antagonists as Targeted Therapy in Oncology
2008
Noncoding RNAs in Vascular Diseases
2020
Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets
2015
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression
2015
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Apoptosis and microRNA aberrations in cancer
2012
Gene silencing by microRNAs: contributions of translational repression and mRNA decay
2011 Standout
Unraveling the Anticancer Effect of Curcumin and Resveratrol
2016
The Pan-Bcl-2 Inhibitor (−)-Gossypol Triggers Autophagic Cell Death in Malignant Glioma
2010
Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets?
2015
An overview of long non-coding RNAs in ovarian cancers
2016
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network
2010
Robust Distal Tip Cell Pathfinding in the Face of Temperature Stress Is Ensured by Two Conserved microRNAS inCaenorhabditis elegans
2015 StandoutNobel
Synthesis and Biological Evaluation of Apogossypolone Derivatives as Pan-active Inhibitors of Antiapoptotic B-Cell Lymphoma/Leukemia-2 (Bcl-2) Family Proteins
2010
Molecular Genetics of Attention-Deficit/Hyperactivity Disorder
2005 Standout
Works of Qing Ji being referenced
Impaired Dihydrotestosterone Catabolism in Human Prostate Cancer: Critical Role of AKR1C2 as a Pre-Receptor Regulator of Androgen Receptor Signaling
2007
Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa
2008
Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation
2020
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
2009
Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression
2015
Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer
2017
Underlying mechanisms and drug intervention strategies for the tumour microenvironment
2021
Frequent loss of estrogen and progesterone receptors in human prostatic tumors determined by quantitative real-time PCR
2004
Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex
2014
Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
2008
Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism
2003
Selective Loss of AKR1C1 and AKR1C2 in Breast Cancer and Their Potential Effect on Progesterone Signaling
2004
[Associations between six functional genes and schizophrenia].
2003
[Clinical analysis of nimotuzumab plus cisplatin and fluorouracil regimen as induction treatment in resectable head and neck squamous cell carcinoma].
2012
Histone demethylase JMJD2C: epigenetic regulators in tumors
2017